Real World Pharma – Affordability vs. Cost Effectiveness. Impressions from 18th ISPOR in Milan
Attending ISPOR when keeping your ear to the ground in Market Access matters is non-negotiable. And this year was no exception. Noticeable to us was that many presentations and workshops revolved around two important and related concepts: affordability and uncertainty. Here is some background. Affordability is very different from cost effectiveness. Cost effectiveness is often […]
